infectious diseases - HealthQuill

The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health agency will license one TB vaccine in a bid to reach 90% of the patients and to end the epidemic.

Global TB report; disease continues to be world’s top infectious killer

HQ Team November 15, 2025: Tuberculosis (TB), an ancient disease that has plagued humanity for millennia, remains a formidable global health crisis. Despite.

by HealthQuill
November 15, 2025
0 Comments

Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child and maternal deaths, combat infectious diseases, Alzheimer’s, and close down the Gates Foundation on December 31, 2045.

Drugs Health Medical

Gates Foundation to shut in 2045, pledges $200 billion in next 20 years

HQ Team May 8, 2025: Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child.

by HealthQuill
May 8, 2025
0 Comments

An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted infections in the world, according to the results of an end-stage study published in The Lancet.

Drugs Health Research

Oral antibiotic shows efficacy in end-stage trials to treat gonorrhoea

HQ Team April 16, 2025: An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted.

by HealthQuill
April 16, 2025
0 Comments

Health Medical Research

New model improves epidemic predictions by leveraging Friendship Paradox

HQ Team January 24, 2025: A recent study led by Empa researchers has developed a new mathematical model that improves predictions of how.

by HealthQuill
January 24, 2025
0 Comments

Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering with the country’s premier science body, the Indian Institute of Science (IISc).

Drugs Medical Research

India’s Tata Group grants $57.8 million to build medical school in IT capital

Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering.

by HealthQuill
January 15, 2025
0 Comments

Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests for tuberculosis.

Uncategorized

Danaher’s Cepheid gets first WHO prequalification nod for TB tests

Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests.

by HealthQuill
December 5, 2024
0 Comments

An illustration of a pair of lungs that are filled with various circles of different colour and size. Some smaller circles are floating outside of the lungs. Image Credit: National Health Service. Metagenomic testing for diagnosis and surveillance

Drugs Health Pharma

UK consortium to build world’s first real-time pandemic surveillance system

The UK, along with a clutch of government and private entities, has set afoot plans to create the world’s first real-time surveillance system.

by HealthQuill
November 5, 2024
0 Comments

A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely ineffective than a normal delivery, a study by the University of Cambridge found.

Drugs Health Pharma

Birth by C-section may double the chance of measles vaccine failure

HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.

by HealthQuill
May 17, 2024
0 Comments

If you are in a hospital, then at times, you get bacterial infections from one source — yourself.

Climate Health Medical

Warming oceans drive flesh-eating bacteria northward, increasing infections

HQ Team April 15,2024:Adding to the climate change worries is the fear Vibrio vulnificus, commonly known as flesh-eating bacteria, is expanding its territory.